Zinc and COVID-19: Basis of Current Clinical Trials

Amit Pal, Rosanna Squitti, Mario Picozza, Anil Pawar, Mauro Rongioletti, Atanu Kumar Dutta, Sibasish Sahoo, Kalyan Goswami, Praveen Sharma, Rajendra Prasad

Research output: Contribution to journalReview articlepeer-review


Coronavirus disease-2019 (COVID-19) pandemic continues to threaten patients, societies, and economic and healthcare systems around the world. Like many other diseases, the host immune system determines the progress of COVID-19 and fatality. Modulation of inflammatory response and cytokine production using immunonutrition is a novel concept that has been applied to other diseases as well. Zinc, one of the anti-inflammatory and antioxidant micronutrient found in food with well-established role in immunity, is currently being used in some clinical trials against COVID-19. This review integrates the contemporary studies of role of zinc in antiviral immunity along with discussing its potential role against COVID-19, and ongoing COVID-19 clinical trials using zinc.

Original languageEnglish
Number of pages11
JournalBiological Trace Element Research
Publication statusE-pub ahead of print - Nov 22 2020


  • Clinical trials
  • COVID-19
  • Immunity
  • Zinc

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical
  • Inorganic Chemistry


Dive into the research topics of 'Zinc and COVID-19: Basis of Current Clinical Trials'. Together they form a unique fingerprint.

Cite this